.

By LACHLAN MOORHEAD

THE medication for an ultra-rare blood disease is still not guaranteed to be subsidised by the Federal Government despite a recent recommendation from the Pharmaceutical Benefits Advisory Committee (PBAC).
Soliris, the most effective treatment available for the rare atypical haemolytic uraemic syndrome (aHUS), was recommended by PBAC to be listed on the Pharmaceutical Benefits Scheme (PBS) at a meeting last month but pricing negotiations between the Federal Government and Soliris’ manufacturer Alexion Pharmaceuticals are still ongoing, with seemingly no end in sight.
Without subsidisation, Soliris is estimated to cost Australian patients roughly $500,000 a year.
Federal MP for La Trobe Jason Wood, who recently met again with nine-year-old aHUS sufferer Holly Van Der Loop and her Narre Warren family, said the process of having Soliris placed on the PBS was only half way.
“It’s great to hear that the PBAC has recommended Soliris to be listed on the PBS, news that we’ve been waiting to hear for a while now,” he said.
“Unfortunately though, we’re only about 50 per cent of the way through the process.
“A positive PBAC recommendation is a very important step in the listing process, but other steps need to be taken before a listing is achieved.
“Pricing negotiations, finalisation of the condition for listing, and quality and availability checks all have to be done before we can breathe a full sigh of relief.”
Holly was diagnosed with aHUS in October 2012, a life-threatening disease that can severely damage the kidneys, heart and brain, and which affects only two in one million Victorians.
Holly’s mother Linda thanked Mr Wood for pushing to have Soliris subsidised, and said the medication was currently beyond the reach of “everyday Australians”.
“I hope that it will be subsidised because if Holly needs it in the future, it’s something that a normal everyday family can’t afford,” she said.
While Holly’s condition has now stabilised, Linda is frighteningly aware of the rate of recurrence of the disease.
“I’m worried that every time she goes to school, she’ll contract an infection which could trigger another aHUS episode,” Linda said.
“I don’t know if Holly’s body could cope with another attack and having plasma exchange again.”
For more information, or to sign the aHUS Patient Support Group Australia petition, visit www.ahus.com.au

Comments are closed.

More News

An 18-year-old man from City of Casey has pleaded guilty to setting fire and damaging a roof during a recent “...

Fountain Gate Secondary College was awash in music, dance and costume for its cultural Diversity event on 24 March. Students performed ...

Children enjoyed a long list of treats, including a fire truck, jumping castle and animal farm, at an open day ...

It was like meeting military royalty in the vaunted vaults of the Shrine of Remembrance on 22 March. At a fund-raising ...

A Clyde North man has been charged with attempted murder after an alleged axe attack on a woman at Fountain ...

A man has been arrested after allegedly attacking a woman with an axe at Fountain Gate Shopping Centre on Monday 27 ...

Latest Sport

DDCA TURF 1 GRAND FINAL PREVIEW HEINZ-SOUTHERN DISTRICTS v MORDIALLOC WHEN and WHERE: 25 and 26 March, Arch Brown Reserve, Berwick It was ...

DDCA TWENTY20 GRAND FINAL PREVIEW BUCKLEY RIDGES v CRANBOURNE WHEN: Wednesday 22 February, 5.15pm. WHERE: Park Oval, Dandenong. In one of ...

AFL WOMEN’S LEAGUE REVIEW – ROUND 2 Melbourne has recorded their first AFLW victory, comfortably knocking off a disappointing Collingwood side ...